Applied Molecular Transport, Inc. (AMTI)
NASDAQ:AMTI
US Market

Applied Molecular Transport (AMTI) Stock Price & Analysis

119 Followers

AMTI Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.21 - $4.17
Previous Close$0.27
Volume235.16K
Average Volume (3M)141.76K
Market Cap
$10.62M
Enterprise Value$3.90M
Total Cash (Recent Filing)$41.77M
Total Debt (Recent Filing)$35.05M
Price to Earnings (P/E)>-0.1
Beta1.74
Aug 15, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.87
Shares Outstanding39,337,933
10 Day Avg. Volume83,963
30 Day Avg. Volume141,762
Standard Deviation0.25
R-Squared0.17
Alpha-0.11
Financial Highlights & Ratios
Price to Book (P/B)-0.78
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.59
Enterprise Value/Gross Profit1.59
Enterprise Value/Ebitda-0.04
Forecast
Price Target Upside270.37% Upside
Rating ConsensusHold
Number of Analyst Covering2


Financials

Annual

Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

AMTI FAQ

What was Applied Molecular Transport, Inc.’s price range in the past 12 months?
Applied Molecular Transport, Inc. lowest stock price was $0.21 and its highest was $4.17 in the past 12 months.
    What is Applied Molecular Transport, Inc.’s market cap?
    Currently, no data Available
    When is Applied Molecular Transport, Inc.’s upcoming earnings report date?
    Applied Molecular Transport, Inc.’s upcoming earnings report date is Aug 15, 2023 which is in 79 days.
      How were Applied Molecular Transport, Inc.’s earnings last quarter?
      Applied Molecular Transport, Inc. released its earnings results on May 11, 2023. The company reported -$0.71 earnings per share for the quarter, missing the consensus estimate of -$0.555 by -$0.155.
        Is Applied Molecular Transport, Inc. overvalued?
        According to Wall Street analysts Applied Molecular Transport, Inc.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Applied Molecular Transport, Inc. pay dividends?
          Applied Molecular Transport, Inc. does not currently pay dividends.
          What is Applied Molecular Transport, Inc.’s EPS estimate?
          Applied Molecular Transport, Inc.’s EPS estimate is $0.23.
            How many shares outstanding does Applied Molecular Transport, Inc. have?
            Applied Molecular Transport, Inc. has 39,337,933 shares outstanding.
              What happened to Applied Molecular Transport, Inc.’s price movement after its last earnings report?
              Applied Molecular Transport, Inc. reported an EPS of -$0.71 in its last earnings report, missing expectations of -$0.555. Following the earnings report the stock price went down -3.571%.
                Which hedge fund is a major shareholder of Applied Molecular Transport, Inc.?
                Among the largest hedge funds holding Applied Molecular Transport, Inc.’s share is Moore Capital Management LP. It holds Applied Molecular Transport, Inc.’s shares valued at N/A.

                  ---

                  Applied Molecular Transport Stock Smart Score

                  This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Applied Molecular Transport, Inc.

                  Applied Molecular Transport Inc is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Its proprietary technology platform allows it to exploit existing natural cellular trafficking pathways to facilitate the active transport of therapeutic payloads across the intestinal epithelium (IE) barrier. Its product candidate, AMT-101, is an oral IL-10 fusion protein that has been designed for active transport across the IE barrier into local GI tissue. IL-10 is a potent immunomodulatory cytokine that is known to be the master regulator of immune homeostasis, including within GI mucosal tissue.

                  ---

                  Top 5 ETFs holding AMTI

                  Name
                  Market Value
                  Smart Score
                  iShares Core S&P Total U.S. Stock Market ETF
                  $4.48K
                  8
                  Up to five ETFs with an Outperform Smart Score that hold AMTI. The ETFs are listed according to market value of AMTI within the ETF

                  ---

                  Forecast EPS vs Actual EPS


                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  IN8bio
                  NextCure
                  Cyclerion Therapeutics
                  Gain Therapeutics
                  Sera Prognostics

                  Popular Stocks

                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis